These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 26500461)

  • 21. Identification of a (CUG)n triplet repeat RNA-binding protein and its expression in myotonic dystrophy.
    Timchenko LT; Miller JW; Timchenko NA; DeVore DR; Datar KV; Lin L; Roberts R; Caskey CT; Swanson MS
    Nucleic Acids Res; 1996 Nov; 24(22):4407-14. PubMed ID: 8948631
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Myotonic dystrophy: the role of the CUG triplet repeats in splicing of a novel DMPK exon and altered cytoplasmic DMPK mRNA isoform ratios.
    Tiscornia G; Mahadevan MS
    Mol Cell; 2000 Jun; 5(6):959-67. PubMed ID: 10911990
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Unraveling water's entropic mysteries: a unified view of nonpolar, polar, and ionic hydration.
    Ben-Amotz D; Underwood R
    Acc Chem Res; 2008 Aug; 41(8):957-67. PubMed ID: 18710198
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Altered phosphorylation and intracellular distribution of a (CUG)n triplet repeat RNA-binding protein in patients with myotonic dystrophy and in myotonin protein kinase knockout mice.
    Roberts R; Timchenko NA; Miller JW; Reddy S; Caskey CT; Swanson MS; Timchenko LT
    Proc Natl Acad Sci U S A; 1997 Nov; 94(24):13221-6. PubMed ID: 9371827
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of a QM/MM-based FEP method to evaluate the anomalous hydration behavior of simple alkyl amines and amides: application to the design of FBPase inhibitors for the treatment of type-2 diabetes.
    Reddy MR; Singh UC; Erion MD
    J Am Chem Soc; 2011 Jun; 133(21):8059-61. PubMed ID: 21545145
    [TBL] [Abstract][Full Text] [Related]  

  • 26. RNA CUG repeats sequester CUGBP1 and alter protein levels and activity of CUGBP1.
    Timchenko NA; Cai ZJ; Welm AL; Reddy S; Ashizawa T; Timchenko LT
    J Biol Chem; 2001 Mar; 276(11):7820-6. PubMed ID: 11124939
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protein-Ligand Binding Free Energy Calculations with FEP.
    Wang L; Chambers J; Abel R
    Methods Mol Biol; 2019; 2022():201-232. PubMed ID: 31396905
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Disruption of splicing regulated by a CUG-binding protein in myotonic dystrophy.
    Philips AV; Timchenko LT; Cooper TA
    Science; 1998 May; 280(5364):737-41. PubMed ID: 9563950
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Ligand That Targets CUG Trinucleotide Repeats.
    Li J; Matsumoto J; Bai LP; Murata A; Dohno C; Nakatani K
    Chemistry; 2016 Oct; 22(42):14881-14889. PubMed ID: 27573860
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Colocalization of muscleblind with RNA foci is separable from mis-regulation of alternative splicing in myotonic dystrophy.
    Ho TH; Savkur RS; Poulos MG; Mancini MA; Swanson MS; Cooper TA
    J Cell Sci; 2005 Jul; 118(Pt 13):2923-33. PubMed ID: 15961406
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An expanded CTG trinucleotide repeat causes trans RNA interference: a new hypothesis for the pathogenesis of myotonic dystrophy.
    Sasagawa N; Takahashi N; Suzuki K; Ishiura S
    Biochem Biophys Res Commun; 1999 Oct; 264(1):76-80. PubMed ID: 10527844
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of type 1 myotonic dystrophy by engineering site-specific RNA endonucleases that target (CUG)(n) repeats.
    Zhang W; Wang Y; Dong S; Choudhury R; Jin Y; Wang Z
    Mol Ther; 2014 Feb; 22(2):312-320. PubMed ID: 24196578
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expansion of CUG RNA repeats causes stress and inhibition of translation in myotonic dystrophy 1 (DM1) cells.
    Huichalaf C; Sakai K; Jin B; Jones K; Wang GL; Schoser B; Schneider-Gold C; Sarkar P; Pereira-Smith OM; Timchenko N; Timchenko L
    FASEB J; 2010 Oct; 24(10):3706-19. PubMed ID: 20479119
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Utilizing the GAAA tetraloop/receptor to facilitate crystal packing and determination of the structure of a CUG RNA helix.
    Coonrod LA; Lohman JR; Berglund JA
    Biochemistry; 2012 Oct; 51(42):8330-7. PubMed ID: 23025897
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of two nuclear proteins which bind to RNA CUG repeats: significance for myotonic dystrophy.
    Bhagavati S; Ghatpande A; Leung B
    Biochem Biophys Res Commun; 1996 Nov; 228(1):55-62. PubMed ID: 8912635
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeting toxic RNAs that cause myotonic dystrophy type 1 (DM1) with a bisamidinium inhibitor.
    Wong CH; Nguyen L; Peh J; Luu LM; Sanchez JS; Richardson SL; Tuccinardi T; Tsoi H; Chan WY; Chan HY; Baranger AM; Hergenrother PJ; Zimmerman SC
    J Am Chem Soc; 2014 Apr; 136(17):6355-61. PubMed ID: 24702247
    [TBL] [Abstract][Full Text] [Related]  

  • 37. FISH Protocol for Myotonic Dystrophy Type 1 Cells.
    Klein AF; Arandel L; Marie J; Furling D
    Methods Mol Biol; 2020; 2056():203-215. PubMed ID: 31586350
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In Vitro Synthesis and RNA Structure Probing of CUG Triplet Repeat RNA.
    van Cruchten RTP; Wansink DG
    Methods Mol Biol; 2020; 2056():187-202. PubMed ID: 31586349
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Coexpression of the CUG-binding protein reduces DM protein kinase expression in COS cells.
    Takahashi N; Sasagawa N; Usuki F; Kino Y; Kawahara H; Sorimachi H; Maeda T; Suzuki K; Ishiura S
    J Biochem; 2001 Nov; 130(5):581-7. PubMed ID: 11686919
    [TBL] [Abstract][Full Text] [Related]  

  • 40. RNA interference targeting CUG repeats in a mouse model of myotonic dystrophy.
    Sobczak K; Wheeler TM; Wang W; Thornton CA
    Mol Ther; 2013 Feb; 21(2):380-7. PubMed ID: 23183533
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.